Clinical study on treatment of primary headache with liver-yang hyperactivity syndrome by He-Sea acupoints

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042868

Enrollment

Unknown

Registered

2021-01-30

Start date

2021-01-30

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary headache

Interventions

1:He-Sea acupoints prescription

2:Routine acupuncture prescription

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of Western medicine and traditional Chinese medicine for primary headache; 2. Patients aged 18-70 years old; 3. Male and female are not limited; 4. Patients who have not received all kinds of treatment measures related to the disease in recent one month; 5. The patients who signed the informed consent form voluntarily participated in and obeyed the arrangement of the research group and insisted on completing the treatment.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients suffering from diseases of important organs or other diseases that may seriously endanger life; 3. Patients with headache but accompanied by other diseases, such as post-traumatic brain syndrome and brain organic lesions; 4. Patients with acupuncture sickness or allergic constitution.

Design outcomes

Primary

Measure	Time frame
VAS;Headache symptom score;TCCD;	—

Secondary

Measure	Time frame
SF-36;	—

Countries

China

Contacts

Public ContactHongling Jia

The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine

18254178199@163.com+86 18254178199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026